Charles J. Casamento - 22 Sep 2021 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
Director
Signature
/s/ Charles J. Casamento
Issuer symbol
RLMD
Transactions as of
22 Sep 2021
Net transactions value
-$145,400
Form type
4
Filing time
24 Sep 2021, 17:00:49 UTC
Previous filing
19 Aug 2021
Next filing
26 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLMD Common Stock Options Exercise $46,000 +10,000 +152% $4.60 16,600 22 Sep 2021 Direct
transaction RLMD Common Stock Sale $55,100 -1,900 -11% $29.00 14,700 22 Sep 2021 Direct F1
transaction RLMD Common Stock Sale $95,700 -3,300 -22% $29.00 11,400 22 Sep 2021 Direct F1
transaction RLMD Common Stock Sale $40,600 -1,400 -12% $29.00 10,000 22 Sep 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLMD Options to purchase common stock Options Exercise $0 -1,900 -1.9% $0.000000 97,311 22 Sep 2021 Common Stock 1,900 $3.24 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020.
F2 The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period..
F3 Not applicable